4
Changes in Ownership
AbCellera Biologics Inc. Filed Acc 0001209191-22-013012
Chief Executive Officer acquired 56,125 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hansen Carl L. G. Chief Executive Officer | 2022-02-22 | Option exercise | +56,125 | $2.70 | $151,538 | 280,625 | D |
| Derivatives | |||||||
| Hansen Carl L. G. Chief Executive Officer | 2022-02-22 | Option exercise · Share option (right to buy) | −56,125 | 5,856,997 | D | ||
Loading xslF345X03/doc4.xml…